Details for Patent: 5,047,398

Summary for Patent: 5,047,398

Title:	DDAVP antidiuretic and method therefor
Abstract:	There is disclosed, in one aspect, an antidiuretic composition in oral dosage form for humans. This composition comprises an antidiuretically effective amount of 1-deamino-8-D-arginine vasopressin (DDAVP) and a pharmaceutically acceptable carrier. The composition is capable of dissolving and being absorbed in the gastrointestinal tract of a human. The composition isused in tablet, capsule, or other generally accepted oral dosage form and generally from about 50 to about 200 micrograms of DDAVP is used per unit dosage In another aspect, there is disclosed a method for treating diabetes insipidus. This method comprises orally administering an antidiuretically effective amount of DDAVP to a human. The DDAVP is substantially dissolved and absorbed in the gastrointestinal tract of the person so treated.
Inventor(s):	Hagstam; Helmer (Malmo, SE), Vilhardt; Hans (Espergarde, DK)
Assignee:	Ferring B.V. (Haarlen, NL)
Application Number:	06/809,937
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form; Use;

Drugs Protected by US Patent 5,047,398

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 5,047,398

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	8306367	Nov 18, 1983

International Family Members for US Patent 5,047,398

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	52187
Australia	3673484
Australia	577338